Efficiency of a myogenic DNA vaccine is strictly dependent upon cellular localization of HIV-1 Pr55 gag

By Bojak A.   Wild J.   Wolf H.   Wagner R.  

Vaccine, Vol. 20, Iss. 15, 2002-05 ,pp. : 1980-1984

Elsevier

Access to resources Recommend Favorite

Effect of different promoters on immune responses elicited by HIV-1 gag/env multigenic DNA vaccine in Macaca mulatta and Macaca nemestrina

By Galvin T.A.   Muller J.   Khan A.S.  

Vaccine, Vol. 18, Iss. 23, 2000-05 ,pp. : 2566-2583

Elsevier

Access to resources Recommend Favorite

Safety and immunogenicity of HIV-1 DNA constructs in chimpanzees

By Bagarazzi M.L.   Boyer J.D.   Ugen K.E.   Javadian M.A.   Chattergoon M.   Shah A.   Bennett M.   Ciccarelli R.   Carrano R.   Coney L.   Weiner D.B.  

Vaccine, Vol. 16, Iss. 19, 1998-11 ,pp. : 1836-1841

Elsevier

Access to resources Recommend Favorite

Safety and immunogenicity of live, attenuated human rotavirus vaccine 89-12

By Bernstein D.I.   Smith V.E.   Sherwood J.R.   Schiff G.M.   Sander D.S.   DeFeudis D.   Spriggs D.R.   Ward R.L.  

Vaccine, Vol. 16, Iss. 4, 1998-02 ,pp. : 381-387

Elsevier

Access to resources Recommend Favorite

Mucosal immunization with HIV-1 gag DNA on cationic microparticles prolongs gene expression and enhances local and systemic immunity

By Singh M.   Vajdy M.   Gardner J.   Briones M.   O'Hagan D.  

Vaccine, Vol. 20, Iss. 3, 2001-11 ,pp. : 594-602

Elsevier

Access to resources Recommend Favorite